Saturday, May 23, 2015 6:39:26 AM
Dr. Pierce's goal from the beginning was a Combo IL12+Keytruda via EP treatment. $ONCS's 1200 to 1400 watts EP opens up the cancer's protective walls forcing immunogenicity factors to enter and transmit messengers back to one's body central control that then send out NK cells to destroy cancer the enemy.
$ONCS EP+IL12 is a producer of CD8 TILs, immunogenicity biologic component. The EP would also increase the penetration of Keytruda. Thereby the immunogenicty factors working in synchronous harmony producing more NKs resulting in increased ORR destroying more cancer than either IL12 or Keytruda alone. For Dr. Pierce a dream fruition materializing.
Recent ONCSQ News
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 02/13/2024 07:30:19 PM
FEATURED Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • Sep 24, 2024 8:50 AM
FEATURED Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM